Condition
AChR Myasthenia Gravis clinical trials and research
Research outlook What's coming for Myasthenia gravis: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 AChR Myasthenia Gravis clinical trials that are recruiting, in United States. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
Efgartigimod for hospitalized myasthenia gravis exacerbations or crisis
This will try giving efgartigimod in the hospital to see if it helps adults with AChR‑positive generalized myasthenia gravis who are admitted for a severe worsening of symptoms.
Related topics
Quick answers
How many AChR Myasthenia Gravis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.